Image For Activity Cover
ITLPEDUC2303 - CME/CMLE - Castleman Disease
Course Description

Castleman Disease: Case-based Microlearning 

 Activity Overview 

This CME/CMLE-accredited, case-based microlearning activity is designed to help laboratory team members increase their knowledge, skills, and competence in diagnosing multicentric Castleman disease and to be informed of changes in clinical practice guidelines. Through a series of four 15-minute cases developed by a multidisciplinary team, you will gain a greater understanding of multicentric Castleman disease, how to differentiate it from potential mimics, and updated guidelines for diagnosis.  

The activity offers 1.0 CME/CMLE credit. 

Target Audience 

The target audience for this activity consists of pathologists and laboratory professionals.    

Activity Agenda 

  • Introduction to Castleman disease 

  • Case-based approach to diagnosing Castleman disease, featuring multidisciplinary perspectives 

Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.  

Credit Designation Statement 

The ASCP designates this online microlearning activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  

ASCP designates this online microlearning activity for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel. 

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time  

Method of Participation 
To complete the activity and receive credit, the participant must complete all four cases in the microlearning activity. CME certificates will be provided online.  

 Commercial Support
This activity is funded by an independent educational grant from Recordati Rare Diseases Inc.. 


Faculty/Authors

Anamarija Perry, MD
Associate Professor, Hematopathology, Department of Pathology, Michigan Medicine, University of Michigan
David Fajgenbaum, MD, MBA, MSc
Assistant Professor of Medicine, Translational Medicine & Human Genetics, University of Pennsylvania
Seth Kligerman, MD
Professor, Division Chief of Cardiothoracic Radiology, Department of Radiology, University of California, San Diego

CME/CMLE Credit: 1.0
Estimated Completion Time: 1 hour
Format: Online Educational Activity

Physician Competencies: Patient Care, Medical Knowledge, Practice-Based Learning, and Improvement  

Accreditation Statement:
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).


Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Review the Faculty Disclosures.
  3. Click Go to Course to view an overview of the modules in this course.
  4. Click Access to begin the course.
  5. Review the Educational Activity.
  6. Submit the course Evaluation.
  7. Enter the maximum number of credits offered and click Claim CME to register credit.

Faculty Disclosures

Technical Considerations

Release Date: 2/9/2023  
Review Date:
Expiration Date: 2/9/2026  

Course Objectives
Following completion of this activity, you will be able to:
  • Discuss the characteristics of Castleman disease, including the disease pathology and radiographic and morphological features
  • Differentiate Castleman disease from potential mimics
  • Describe current therapies for the management of multicentric Castleman disease
Summary
Availability: On-Demand
Credit Offered:
1 CME/CMLE Credit
Powered By